How We Ranked These
Every food on this list was scored using KibbleIQ’s ingredient analysis rubric, which evaluates protein quality, filler content, preservative safety, and ingredient transparency on a 0–100 scale. For feline primary hyperaldosteronism, we cross-referenced Ash 2005 (landmark contemporary PHA clinical outcomes and surgical framework), Harvey 2004 (feline adrenal tumors review), Flood 1999 (original feline PHA case series), Javadi 2005 (PHA feline diagnostic framework), Schulman 2010 (PHA endocrinology review), MacKay 1999 (feline hypokalemic polymyopathy review), Rose 2007 (feline aldosteronism update), Daniel 2016 (long-term outcomes with medical vs. surgical management), Lo 2014 (feline adrenalectomy surgical review), Scansen 2011 (feline systemic hypertension management), AAFP 2016 Senior Care Guidelines (older-cat PHA demographic), Zoran 2002 (obligate carnivore framework that shapes feline electrolyte and protein feeding), WSAVA Global Nutrition Guidelines, NRC 2006 cat nutrient requirements, and ACVIM 2018 systemic hypertension consensus. We also considered Djajadiningrat-Laanen 2011 (PHA prevalence estimates in senior cats — possibly 8% of senior feline hypertension cases) and Reusch 2017 (feline endocrine disease review).
PHA clinical presentation: cervical ventroflexion (chin-to-chest flexion from neck muscle weakness, the classic clinical sign), generalized weakness, occasional acute flaccid paralysis during severe hypokalemia, polyuria/polydipsia, retinal detachment from severe hypertension, and progression to CKD from hypertensive nephropathy. Diagnostic framework per Ash 2005 + Schulman 2010: plasma aldosterone (elevated) + plasma renin (suppressed) yielding elevated aldosterone-to-renin ratio, plus abdominal imaging (ultrasound for adrenal mass identification; CT for pre-surgical planning), plus serum potassium (low), plus blood pressure (high). Medical management is lifelong for non-surgical cases and typically ~4–6 weeks pre-surgical for cases with planned adrenalectomy. Diet supports but does not replace spironolactone-plus-potassium-plus-amlodipine therapy.
Our Top 5 Picks
1. Wellness CORE Cat — A (90/100)
Wellness CORE Cat leads our PHA recommendations because the high-animal-protein grain-free formulation provides strong muscle-supportive protein (for the hypokalemic myopathy recovery phase) with balanced mineral profile that avoids the unintentionally-low-sodium trap that plagues some grain-free or limited-ingredient formulations. Per Scansen 2011 and ACVIM 2018 systemic hypertension consensus, low-sodium diets are NOT beneficial in feline hypertension (unlike human hypertension) — the evidence for sodium restriction in cats is weak, and excessive sodium restriction activates the renin-angiotensin system paradoxically. Wellness CORE’s balanced sodium delivery (moderate, not low) aligns with contemporary feline-hypertension management. Three-strain probiotic supports GI health during spironolactone therapy (occasional nausea at initiation per Lo 2014).
Best high-protein balanced-mineral pick for hypokalemic myopathy recovery. Read our full Wellness CORE Cat review → · Shop on Amazon →
2. Acana Cat — A (90/100)
Acana Cat’s Champion Petfoods WholePrey formulation includes bone-in variety meats that provide natural mineral balance — calcium, phosphorus, potassium in physiologic ratios that align with obligate-carnivore evolutionary feeding per Zoran 2002. The multi-protein sourcing (chicken, turkey, fish, variety meats) supports muscle-mass preservation for PHA cats recovering from hypokalemic myopathy (cervical ventroflexion and generalized weakness often persist for weeks after potassium normalization per MacKay 1999, and muscle-mass recovery benefits from high-bioavailable-protein feeding). Cooked-kibble format provides the formulation-consistency advantage relevant for chronic endocrine-disease feeding.
Best multi-protein WholePrey option for muscle-mass recovery. Read our full Acana Cat review → · Shop on Amazon →
3. Nulo Cat — B (88/100)
Nulo Freestyle Cat’s salmon-forward formulations provide marine-sourced protein at moderate sodium levels — salmon and fish proteins carry somewhat higher inherent potassium density than poultry or red-meat proteins, a modest advantage for PHA cats on potassium supplementation who benefit from dietary-source potassium as a complementary input alongside oral potassium gluconate or potassium citrate supplementation. BC30 probiotic addition supports GI resilience during extended medical-management courses. Amlodipine (co-administered for hypertension in PHA cats per Scansen 2011) can occasionally cause GI upset; probiotic support buffers this.
Best salmon-forward pick with modest dietary-potassium advantage. Read our full Nulo Cat review → · Shop on Amazon →
4. American Journey Cat — B (82/100)
American Journey Cat provides premium-adjacent quality at Chewy private-label pricing — important for PHA cat owners whose monthly costs are elevated from lifelong spironolactone prescriptions, oral potassium supplementation, amlodipine for hypertension, serial blood pressure monitoring, and serial bloodwork for aldosterone-potassium-renal-function tracking. Chicken First and Salmon First variants both provide strong animal-protein-forward profiles. The budget-premium positioning allows sustainable long-term feeding for the chronic-disease scenario where PHA cats on medical management live 2–3+ years with attentive monitoring per Daniel 2016.
Best budget-premium for long-term chronic endocrine-disease feeding. Read our full American Journey Cat review → · Shop on Amazon →
5. Instinct Raw Boost Cat — B (79/100)
Instinct Raw Boost provides high-protein freeze-dried-raw-coated kibble that delivers palatability premium during the hypokalemic-myopathy recovery phase when appetite may be reduced from muscle fatigue, depression, and lethargy. The raw-coating format amplifies aroma volatiles (relevant for cats with comorbid chronic-rhinitis sequelae from older FHV-1 exposure) and delivers freeze-dried raw-meat aromatics on a cooked kibble substrate (safe for non-immunocompromised PHA cats; contraindicated only for concurrent FeLV+ or FIV+ or chemotherapy-treated cats per AAFP 2020). Strong muscle-supportive protein profile aligns with the recovery-from-myopathy priority.
Best palatability-premium pick for appetite-compromised recovery phase. Read our full Instinct Raw Boost Cat review → · Shop on Amazon →
What to Look for in Food for a Cat with Hyperaldosteronism
Moderate sodium — do NOT low-salt a hypertensive PHA cat. Per Scansen 2011, ACVIM 2018 systemic hypertension consensus, and AAFP 2016, the evidence for dietary sodium restriction in feline hypertension (including PHA-driven hypertension) is weak, and extreme sodium restriction triggers compensatory renin-angiotensin-aldosterone activation that can worsen hypertension paradoxically. The feline-specific evidence base differs from the human hypertension paradigm: in humans, sodium restriction has robust efficacy; in cats, it does not, and the amlodipine + potassium + spironolactone pharmacologic regimen carries essentially all the blood pressure workload. Moderate sodium (not excessively-low, not excessively-high) is the target — typical commercial cat foods in the moderate-quality-and-premium tier meet this. Do not select “low sodium” or “salt-free” specialty formulations for PHA cats unless specifically directed by your veterinarian.
Oral potassium supplementation carries the potassium workload, not diet. Per Flood 1999 and Lo 2014, PHA cats require oral potassium gluconate or potassium citrate supplementation (target dose 2–6 mEq per cat per day, adjusted based on serial serum potassium) alongside spironolactone. The supplementation dose far exceeds what dietary manipulation can provide — no commercial cat food delivers pharmacologic potassium doses. Diet provides dietary-source potassium as a complementary input (slightly higher in fish-forward formulations per the Nulo pick above) but supplementation remains the primary pharmacologic tool. Do not substitute “high-potassium cat food” claims (rarely evidence-backed) for prescribed oral potassium supplementation.
Adrenalectomy is curative for solitary adenoma — feeding differs peri-surgically. Per Ash 2005 and Lo 2014, unilateral adrenalectomy for solitary aldosterone-secreting adenoma is curative in 70–85% of surgical candidates with median survival 2+ years. The pre-surgical 4–6-week window uses medical management (spironolactone + potassium + amlodipine) to optimize electrolyte and blood-pressure status before general anesthesia and surgery. Post-surgical recovery involves a 7–14-day prescription-gastrointestinal-support diet period (Hill’s Rx i/d Feline, Royal Canin Gastrointestinal) before transition back to long-term maintenance feeding. Cats with bilateral adrenal hyperplasia (the minority form) require lifelong medical management rather than surgical cure, and the long-term feeding framework above applies. For general post-surgical recovery feeding framework, see our post-surgery recovery guide.
Watch for concurrent CKD — adjust feeding framework if kidney disease develops. Per Scansen 2011 and Daniel 2016, untreated or medically-managed PHA produces hypertensive nephropathy in a meaningful fraction of affected cats over 1–2-year disease courses, progressing to IRIS Stage 2–3 CKD. Post-CKD-onset, the feeding framework shifts toward the standard feline CKD management — moderate-protein-but-high-quality (not severe protein restriction per Plantinga 2005 + AAFP 2016), phosphorus restriction, omega-3 support, maintained hydration. Our kidney disease guide covers the IRIS-staged CKD feeding framework; our senior kidney guide covers the senior-cat-CKD angle that overlaps with PHA demographic (most PHA cats are senior per Harvey 2004). The PHA + CKD combination requires individual veterinary-nutrition consultation; neither guide alone fully captures the dual framework.
Compare to other feline endocrine conditions for scope clarity. Per Reusch 2017, feline endocrine disease encompasses hyperthyroidism (more common than PHA by several orders of magnitude in typical geriatric-feline practice), diabetes mellitus (also far more common than PHA), hyperaldosteronism (PHA, the subject of this guide), hyperadrenocorticism (Cushing’s disease, rare in cats), acromegaly (feline pituitary growth-hormone-secreting tumor, increasingly recognized), and rare primary hypoadrenocorticism (Addison’s disease, very rare in cats). PHA shares the endocrine-chronic-disease framework with hyperthyroidism (Session 20) and diabetes, but the specific electrolyte and blood-pressure focus of PHA is distinct — hyperthyroidism primarily drives weight loss, polyphagia, and hypertension (different mechanism); diabetes drives insulin-resistance management (different primary focus). Owners and veterinarians sometimes conflate these; the clinical signs of cervical ventroflexion + hypokalemia + hypertension + elevated aldosterone-renin ratio are PHA-specific.
Senior-cat life-stage considerations compound PHA management. Per Harvey 2004 and Djajadiningrat-Laanen 2011, the mean age at PHA diagnosis is 13–14 years — firmly in senior-cat territory with expected comorbidities (sarcopenia, dental disease, occasional concurrent endocrine disease, increased anesthesia-related risk for the surgical-candidate subset). Senior-cat feeding framework applies alongside PHA-specific framing: higher-protein than adult-maintenance to preserve muscle mass per AAFP 2021 Nutritional Assessment, smaller more-frequent meals, attention to dental health given weak cervical musculature from residual hypokalemic myopathy. Our senior cats guide covers the broader senior-cat feeding framework. For concurrent hyperthyroid-or-CKD comorbidities common in senior PHA cats, the multi-condition feeding consultation with your veterinary team becomes particularly important.
Bottom Line
Feline primary hyperaldosteronism is an uncommon but increasingly recognized adrenal endocrine disorder causing hypokalemia and systemic hypertension, with medical management centered on spironolactone + oral potassium supplementation + amlodipine per Ash 2005 + Scansen 2011 framework. Adrenalectomy is curative for solitary adenomas. Dietary management is supportive: moderate sodium (NOT low-salt, which worsens feline hypertension paradoxically), adequate dietary potassium as complementary input to pharmacologic supplementation, and high-quality-animal-protein muscle-supportive feeding for recovery from hypokalemic myopathy. Our top picks: Wellness CORE Cat leads with balanced-mineral high-protein formulation; Acana Cat delivers multi-protein WholePrey with natural mineral balance; Nulo Cat provides salmon-forward moderate-sodium profile; American Journey Cat covers budget-premium for long-term feeding; Instinct Raw Boost Cat delivers palatability premium during recovery phase. Coordinate all PHA management with your veterinary team — serial monitoring of potassium, blood pressure, and aldosterone-renin ratio guides medical-management adjustments, and surgical candidacy evaluation is time-sensitive for solitary-adenoma cases.